Snowball logo
logo
ARCT_logo

Arcturus Therapeutics Holdings Inc

ARCT NASDAQ
$7.21+$0.04  (0.56%)

Frequently asked questions

What sector does Arcturus Therapeutics Holdings Inc (ARCT) operate in?

Arcturus Therapeutics Holdings Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Arcturus Therapeutics Holdings Inc (ARCT) current stock price?

As of the latest data, Arcturus Therapeutics Holdings Inc stock price is $7.21, with a previous close of $7.17. Arcturus Therapeutics Holdings Inc gained $0.04 in the last trading session, representing a 0.56% increase.

What is Arcturus Therapeutics Holdings Inc (ARCT) current market capitalization?

Arcturus Therapeutics Holdings Inc market cap is approximately 204.87 million.

What is Arcturus Therapeutics Holdings Inc (ARCT) Earnings Per Share (EPS)?

The trailing EPS is -$2.46, and the forward EPS is -$2.51.

What is Arcturus Therapeutics Holdings Inc (ARCT) EBITDA?

Arcturus Therapeutics Holdings Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -12.69 million.

Does Arcturus Therapeutics Holdings Inc (ARCT) pay dividends?

No. Arcturus Therapeutics Holdings Inc does not pay a dividend.

How did Arcturus Therapeutics Holdings Inc (ARCT) perform in its most recent earnings report?

In the last report (September 30, 2025), Arcturus Therapeutics Holdings Inc posted an EPS surprise of -108.86% and a revenue surprise of 6.97%.

When is Arcturus Therapeutics Holdings Inc (ARCT) next earnings report?

Arcturus Therapeutics Holdings Inc is expected to release its next earnings report on December 31, 2025.

What is Arcturus Therapeutics Holdings Inc (ARCT) beta (volatility) score?

Arcturus Therapeutics Holdings Inc has a beta of 2.240, indicating very high volatility compared to the market.